At the IGTP TODAY

News

Resistance, chemotherapy and predictive biomarkers

- Campus Can Ruti, Research

The IGTP and the ICO join forces with the IRONMAN Project, the largest international registry for research into metastatic prostate cancer

The Urological Tumour Group of the Catalan Institute of Oncology (ICO-B·ARGO) at the Germans Trias i Pujol Research Institute (IGTP) led by Dr Albert Font Pous in collaboration with the Urology and Radiology Service at the Germans Trias i Pujol Hospital have joined the IRONMAN Project this November.   The project was created and is being mainly financed by the Movember Foundation.

- Campus Can Ruti

A trial in advanced colorectal cancer opens the door to a future blood test to predict the most efficient treatment for reducing metastasis

The study, published in 'Annals of Oncology' aimed to demonstrate that choosing the treatment regime based on genetic variants could improve the prognosis of patients with advanced colorectal cancer. Although this primary objective was not achieved, the trial did show that a blood test can be used to predict the most efficient treatment to reduce metastasis.